| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000227589.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040625879 |
Resistant |
| ENSG00000227589.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.011344262 |
Resistant |
| ENSG00000227589.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.01696431 |
Resistant |
| ENSG00000227589.1 |
Ponatinib |
Colon adenocarcinoma |
0.025352856 |
Resistant |
